» Articles » PMID: 37846263

Digesting the Impact of Diet on Irritable Bowel Syndrome (IBS): Exploring Solutions for Controlling IBS

Overview
Journal Cureus
Date 2023 Oct 17
PMID 37846263
Authors
Affiliations
Soon will be listed here.
Abstract

Irritable bowel syndrome (IBS) plagues nearly a fifth of the general population. It is a chronic illness that can significantly lower quality of life (QoL) and work productivity. The relationship between diet and the functional gastrointestinal (GI) symptoms present in IBS is gaining more and more attention. In addition to being a factor in the pathophysiology of IBS, diet also has a significant impact on symptoms and overall well-being. Recent research has also shown that short-chain fermentable carbohydrates increase colonic gas production and small intestine water volume, which in turn causes functional GI symptoms in those with visceral hypersensitivity. This review article has consolidated various studies highlighting the association between certain foods and the pathophysiology of IBS. It has also talked about how restricting certain food items from the diet of affected individuals can relieve symptoms and in some cases can be more effective than pharmacotherapy. Although the low reduced fermentable oligosaccharide, disaccharide, monosaccharide, and polyol (FODMAP) diet (LFD) is a well-known method of treating IBS symptoms, over a third of individuals do not benefit from it. This article has also discussed the effectiveness and applicability of the LFD compared to other dietary therapies for the long-term management of IBS.

Citing Articles

Dietary astragalin confers protection against lipopolysaccharide-induced intestinal mucosal barrier damage through mitigating inflammation and modulating intestinal microbiota.

Tang E, Lin H, Yang Y, Xu J, Lin B, Yang Y Front Nutr. 2024; 11:1481203.

PMID: 39421621 PMC: 11483603. DOI: 10.3389/fnut.2024.1481203.


The Latest Data Concerning the Etiology and Pathogenesis of Irritable Bowel Syndrome.

Ionescu V, Gheorghe G, Georgescu T, Bacalbasa N, Gheorghe F, Diaconu C J Clin Med. 2024; 13(17).

PMID: 39274340 PMC: 11395839. DOI: 10.3390/jcm13175124.

References
1.
Surdea-Blaga T, Baban A, Dumitrascu D . Psychosocial determinants of irritable bowel syndrome. World J Gastroenterol. 2012; 18(7):616-26. PMC: 3281218. DOI: 10.3748/wjg.v18.i7.616. View

2.
Yao C, Tan H, Van Langenberg D, Barrett J, Rose R, Liels K . Dietary sorbitol and mannitol: food content and distinct absorption patterns between healthy individuals and patients with irritable bowel syndrome. J Hum Nutr Diet. 2013; 27 Suppl 2:263-75. DOI: 10.1111/jhn.12144. View

3.
Ragnarsson G, Bodemar G . Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients' description of diarrhea, constipation and symptom variation during a prospective 6-week study. Eur J Gastroenterol Hepatol. 1998; 10(5):415-21. DOI: 10.1097/00042737-199805000-00011. View

4.
Macfarlane G, Steed H, Macfarlane S . Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J Appl Microbiol. 2008; 104(2):305-44. DOI: 10.1111/j.1365-2672.2007.03520.x. View

5.
Chatterjee S, Park S, Low K, Kong Y, Pimentel M . The degree of breath methane production in IBS correlates with the severity of constipation. Am J Gastroenterol. 2007; 102(4):837-41. DOI: 10.1111/j.1572-0241.2007.01072.x. View